Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2000
11/22/2000CN1274361A Solution phase synthesis of oligonucleotides
11/22/2000CN1274259A Hypersensitive response elicitor from i(pseudomonas syringae) and its use
11/22/2000CN1274010A Characteristic nucleotide sequence and method for discriminating cordyceps
11/22/2000CN1274008A Exoteric expression of hay bacillus cecropi and its method
11/21/2000US6150517 Making a probe for use in nucleic acid hybridization assay by aligning ribosomal rna or encoding dna of target bacterial species to a nontarget species to identify a variable region, then designing target complementary sequence
11/21/2000US6150516 Solid phase supports, each having spatially discrete regions, each region having uniform population of identical tag complements selected from single mimimally cross-hybridizing set of oligonucleotides; large scale sequencing and analysis
11/21/2000US6150508 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/21/2000US6150340 RNA-dependent amidotransferase from Staphylococcus aureus
11/21/2000US6150161 Methods for the diagnosis of glaucoma
11/21/2000US6150150 Human brain phosphodiesterase
11/21/2000US6150147 Laying out a pattern of nucleotide sequences on surface of a substrate; forming layout of nucleic acid sequences on the surface of a substrate and reducing electrostatic charge during process
11/21/2000US6150137 Immunosuppressant target proteins
11/21/2000US6150134 Recombinant microorganism polypeptide; for the diagnosis, treatment and prevention of preferential microorganismal infections; for the purification of recombinant polypeptides
11/21/2000US6150132 Vector coding polypeptides for the diagnosis and treatment of allergies and atherosclerosis; for the prevention of graft ejection and injuries to stem cell caused by anticarcinogenic agents
11/21/2000US6150131 Screening for viricides that suppress interactions between cysteine and palmitic acid; mix cells infected with influenza virus, palmitic acid and modulator, monitor reduction in palmitic acid incorporation
11/21/2000US6150128 Reagents with enhanced performance in clinical diagnostic systems
11/21/2000US6150127 Screening for the presence of a modulator of performance in test species; providing symbiont, insertion into test species, recovering data that indicates transfer of symbiont to test species and performance adjustment
11/21/2000US6150124 Monitoring activation time between test fluid and reagent; monitoring transmission of light through reagent, apply test fluid, monitor light transmission through reagent/test fluid, detect amplified activity, detect time of amplification
11/21/2000US6150119 Serially transferring testing plugs in fluid channel; insertion of first test plug into channel, allow migration to sample detection device, insert second test plug and allow migration, duplicate for subsequent test plugs
11/21/2000US6150117 Detecting cell proliferative defects; detecting thymosin or nucleotide sequences coding thymosin in sample, comparing thymosin content in sample and reference tissue, amplified thymosin in sample is indicator of cell proliferation defect
11/21/2000US6150116 Transcription factor DP-1 antibody
11/21/2000US6150112 Methods for identifying DNA sequences for use in comparison of DNA samples by their lack of polymorphism using Y shape adaptors
11/21/2000US6150110 HMGI(Y)-LAMA4* fusion oncogene, oncoprotein and methods of use
11/21/2000US6150107 Hybridization of oligonucleotide primer; copying fragment with dna polymerase; genetic engineering
11/21/2000US6150105 Generating variable length copies of a nucleic acid from sample, hybridizing to reference nucleic acids, and detecting presence or absence of variations at the 3'-terminal position
11/21/2000US6150104 Nucleotide sequences coding a mutant polypeptide associated with ionic mobility; for the diagnosis of genetic disorders associated with heart arrythmias
11/21/2000US6150102 Method of generating nucleic acid oligomers of known composition
11/21/2000US6150101 Methods of identifying a composition that alters connective tissue growth factor expression
11/21/2000US6150100 Method for the detection of microsatellite instability for tumor diagnostics
11/21/2000US6150099 Detecting modulators of transcription factors; incubating transcription factor and modulator in solution, monitor the level of gene expression
11/21/2000US6150097 Nucleic acid detection probes having non-FRET fluorescence quenching and kits and assays including such probes
11/21/2000US6150096 Polymerase chain reaction primers for the detection of genetic disorders
11/21/2000US6150095 Method for analyzing a polynucleotide containing a variable sequence
11/21/2000US6150093 Unique associated Kaposi's sarcoma virus sequences and uses thereof
11/21/2000US6150091 Direct molecular diagnosis of Friedreich ataxia
11/21/2000US6150090 Nuclear factors associated with transcriptional regulation
11/21/2000US6150089 Method and characterizing polymer molecules or the like
11/21/2000US6149952 Method for determining deleterious bacterial growth in packaged food utilizing hydrophilic polymers
11/21/2000CA2272410A1 Method for diagnosis of hereditary hemochromatosis
11/21/2000CA2127207C Blood culture sensor station utilizing two distinct light sources
11/21/2000CA2089362C Methods of synthesizing oligonucleotides with random codons
11/21/2000CA2014119C Methods and devices for the separation of plasma or serum from whole blood, collection of plasma or serum, and reagent delivery system
11/16/2000WO2000068689A1 Cell separation device and methods for use
11/16/2000WO2000068688A1 Polysaccharide structure and sequence determination
11/16/2000WO2000068687A2 Methods of identifying therapeutic compounds in a genetically defined setting
11/16/2000WO2000068436A1 Detection system for human immunodeficiency virus based on nucleic acid amplification
11/16/2000WO2000068435A1 Method for specifically detecting and identifying retroviral nucleic acids/retroviruses in an item to be examined
11/16/2000WO2000068434A2 Multiple tag analysis
11/16/2000WO2000068433A2 Autism gene
11/16/2000WO2000068432A2 Diagnosis of primary congenital glaucoma
11/16/2000WO2000068431A2 Dna-based steganography
11/16/2000WO2000068430A1 Rnase p polypeptides, polynucleotides, and methods using their mechanisms of action
11/16/2000WO2000068429A2 Diagnosis of glaucoma
11/16/2000WO2000068428A1 Methods for producing modified nucleic acid molecules
11/16/2000WO2000068426A1 Ups
11/16/2000WO2000068424A2 Means for detecting and treating pathologies linked to fgfr3
11/16/2000WO2000068423A2 Improved predictive power of rna analysis for protein expression
11/16/2000WO2000068422A2 High density labeling of dna with modified or 'chromophore' carrying nucleotides and dna polymerases used
11/16/2000WO2000068421A2 Method for detecting microorganisms in a sample
11/16/2000WO2000068420A2 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery
11/16/2000WO2000068418A1 Assays for nucleoside diphosphates and triphospates
11/16/2000WO2000068417A1 Dehydrated immediate reconstruction culture medium to identify group b streptococci streptococcus agalactiae by the detection of their pigment
11/16/2000WO2000068416A2 Method for localising proteases which split substrates that are specifically connected by a membrane
11/16/2000WO2000068415A2 A method for measuring biomolecules
11/16/2000WO2000068414A2 Whole cell assay for cathepsin k
11/16/2000WO2000068411A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
11/16/2000WO2000068410A1 Nucleic acid sequencing with simultaneous quantitation
11/16/2000WO2000068381A1 Cytokine receptor mouse zcytor10
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068379A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000WO2000068367A1 Assay reagent
11/16/2000WO2000068364A2 Mutations in nucleic acid molecules encoding 11-cis retinol dehydrogenase, the mutated proteins, and uses thereof
11/16/2000WO2000068362A2 Undifferentiated erythroid cells and their use in ligand binding assays
11/16/2000WO2000068361A1 Versican and epithelial-mesenchymal interaction
11/16/2000WO2000068360A1 A histidine kinase, 636 hk, of staphylococcus aureus
11/16/2000WO2000068268A1 Human gabab receptor 1 promoters
11/16/2000WO2000068247A2 Serine proteases
11/16/2000WO2000068185A1 A structure-based approach to design inhibitors of protein-processivity factor interactions
11/16/2000WO2000067907A2 Sample evaporative control
11/16/2000WO2000067775A1 Fibroblast growth factor 15
11/16/2000WO2000067761A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000WO2000067737A2 USE OF HMGCoA REDUCTASE INHIBITORS IN THE PREVENTION OF DISEASES WHOSE PATHOGENESIS IS DEPENDENT ON NEOVASCULARIZATION
11/16/2000WO2000067580A1 Method for identifying compounds that modulate eukaryotic splicing
11/16/2000WO2000058502A3 Use of collagenase 3 for detecting destructive diseases of the joints
11/16/2000WO2000049405A3 Detection of pathogens, especially spirochetes, from body fluids
11/16/2000WO2000046602A3 Method for determining the concentration of thrombin inhibitors
11/16/2000WO2000044931A3 High-throughput screening assays for modulators of atpase
11/16/2000WO2000044876A3 Method, vessel and device for monitoring metabolic activity of cell cultures in liquid media
11/16/2000WO2000042204A3 Trans-acting factors in yeast
11/16/2000WO2000039325A3 Affinity sensor for detecting specific molecular binding events and use thereof
11/16/2000WO2000039287A3 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides and uses thereof
11/16/2000WO2000039285A3 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000037613A3 Human akt-3
11/16/2000WO2000036118A3 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
11/16/2000WO2000034511A3 Aβ-PEPTIDE SCREENING ASSAY
11/16/2000WO2000032814A3 Methods for producing selected interstrand cross-links in nucleic acids and applications thereof
11/16/2000WO2000031536A3 Detecting structural or synthetic information about chemical compounds
11/16/2000WO2000031305A3 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids
11/16/2000WO2000028090A3 Diagnostic assay for cancer
1 ... 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 ... 3003